Hypertrophic Cardiomyopathy Lunch & Learn: Novel Treatments for HCM

Join us on four consequent Thursdays for a lunch and learn series on hypertrophic cardiomyopathy. This week’s sessions will cover Hypertrophic Cardiomyopathy: Novel Treatments with Norma Flores DNP, CRNP, AGACNP-BC, AACC, HF-Cert, CCRN.

This is a 4-part lunch and learn series.  You only need to register once but we hope you can join us live for all four sessions. *All sessions will be recorded and saved in your classroom if you miss a live session*

JOIN THE LUNCH AND LEARN

Join us on the following days:

• July 13 – Novel Treatments with Norma Flores, DNP, CRNP, AGACNP-BC, AACC, HF-Cert, CCRN
• July 20 – Patient Access and Team-Based Care with Milind Desai, MD, MBA
• July 27 – Patient Adherence with Matthew Martinez, MD, FACC and Stacey Titus, HCM Patient & Center of Excellence Coordinator
• Aug 3 – Ask the Experts, led by Jane Linderbaum, MS, ARNP, FACC, FPCNA (with guests from previous weeks)

Supported by Bristol-Myers Squibb.

Learning Objectives

July 13  – Hypertrophic Cardiomyopathy: Novel Treatments

1. 1. Identify characteristics of nonobstructive and obstructive HCM
   2. Describe the mechanism of action of cardiac myosin inhibitor
   3. Examine current literature and research into novel HCM treatments
   4. Analyze best clinical practice scenarios

July 20 – Hypertrophic Cardiomyopathy: Patient Access and Team-Based Care

1. 1. Discuss access considerations for novel HCM treatments
   2. Explain potential barriers and related solutions to prescribing a cardiac myosin inhibitor, including prior authorizations and specialty pharmacy considerations
   3. Compare team-based approaches for successful medication administration in clinical setting, pharmacy, and home
   4. List the follow-up echocardiography requirements for HCM management

July 27 – Hypertrophic Cardiomyopathy: Patient Adherence

1. 1. Describe the drug administration pathway from initiation to maintenance
   2. Discuss signs and symptoms that signify a needed dose adjustment
   3. Describe patient HCM treatment journey
   4. Assess team-based care scenarios for improving outcomes for patients taking novel medications

August 3 – Hypertrophic Cardiomyopathy: Ask the Experts

1. 1. Review highlights of team-based care approach to ordering and administering novel HCM pharmaceutical therapy
   2. Using case-based scenarios, identify best practices for prescribing and administering novel medications for HCM
   3. Discuss how to maximize effective communications in team-based care
   4. Describe effective strategies for shared decision-making for patients with HCM and their family